Philogen Statistics

Total Valuation

Philogen has a market cap or net worth of EUR 866.23 million. The enterprise value is 815.53 million.

Market Cap	866.23M
Enterprise Value	815.53M

Important Dates

The last earnings date was Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Philogen has 40.29 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	40.29M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	4.54%
Float	n/a

Valuation Ratios

The trailing PE ratio is 19.13 and the forward PE ratio is 9.86.

PE Ratio	19.13
Forward PE	9.86
PS Ratio	11.16
PB Ratio	6.25
P/TBV Ratio	6.30
P/FCF Ratio	22.40
P/OCF Ratio	21.21
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.60, with an EV/FCF ratio of 21.09.

EV / Earnings	18.01
EV / Sales	10.50
EV / EBITDA	19.60
EV / EBIT	21.61
EV / FCF	21.09

Financial Position

The company has a current ratio of 1.19

Current Ratio	1.19
Quick Ratio	0.92
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	11.48

Financial Efficiency

Return on equity (ROE) is 39.51% and return on invested capital (ROIC) is 19.32%.

Return on Equity (ROE)	39.51%
Return on Assets (ROA)	17.08%
Return on Invested Capital (ROIC)	19.32%
Return on Capital Employed (ROCE)	26.70%
Revenue Per Employee	446,282
Profits Per Employee	260,299
Employee Count	165
Asset Turnover	0.56
Inventory Turnover	13.08

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.26% in the last 52 weeks. The beta is 0.11, so Philogen's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	+17.26%
50-Day Moving Average	19.26
200-Day Moving Average	19.75
Relative Strength Index (RSI)	70.88
Average Volume (20 Days)	11,988

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Philogen had revenue of EUR 77.65 million and earned 45.29 million in profits.

Revenue	77.65M
Gross Profit	41.62M
Operating Income	37.73M
Pretax Income	40.38M
Net Income	45.29M
EBITDA	41.62M
EBIT	37.73M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	138.66M
Book Value Per Share	n/a
Working Capital	3.03M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 40.84 million and capital expenditures -2.17 million, giving a free cash flow of 38.68 million.

Operating Cash Flow	40.84M
Capital Expenditures	-2.17M
Free Cash Flow	38.68M
FCF Per Share	0.96

Full Cash Flow Statement

Margins

Gross margin is 53.60%, with operating and profit margins of 48.59% and 58.33%.

Gross Margin	53.60%
Operating Margin	48.59%
Pretax Margin	52.00%
Profit Margin	58.33%
EBITDA Margin	53.60%
EBIT Margin	48.59%
FCF Margin	49.80%

Dividends & Yields

Philogen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	5.23%
FCF Yield	4.46%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a